Ken Wisniewski

Ken Wisniewski, MBA, is an experienced professional currently serving as the Director of Vaccine Sales for the Northeast at Dynavax Technologies and as a Brigadier General in the New York Army National Guard. Wisniewski has held various leadership roles in the pharmaceutical industry, including Regional Sales Manager at Syneos Health, where a nine-person immunology sales team was built to launch an Adalimumab biosimilar, and Regional Sales Director at Aimmune Therapeutics, responsible for the introduction of the first peanut allergy therapy in the U.S. Prior experience includes managing specialty pharmacy accounts at Sanofi Genzyme and Bioverativ, and holding several positions at Biogen, including National Account Manager. Wisniewski started a professional career at Pfizer after completing a National Security Fellowship at Harvard University and holds an MBA from Bentley University, along with a Bachelor of Science in Business Administration from Bryant University.